SBIR-STTR Award

Reporter assays for tumor promoters
Award last edited on: 1/30/14

Sponsored Program
SBIR
Awarding Agency
NIH : NIEHS
Total Award Amount
$50,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Lawrence M Ballas

Company Information

Sphinx Pharmaceutical Corporation (AKA: Sphinx Biotechnologies Corporation)

4 University Place Box 52330
Durham, NC 27707
   (919) 489-0909
   N/A
   N/A
Location: Single
Congr. District: 01
County: Durham

Phase I

Contract Number: N43ES081003-000
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1988
Phase I Amount
$50,000
The long term goals are to develop a simple, rapid and inexpensive assay for the identification of tumor promoting compounds present in the environment. The proposed method capitalizes on recent molecular findings on the mechanism by which tumor promoters regulate the expression of specific genes. These genes contain phorbol ester responsive elements in their 5' non-coding regions. Plasmid constructs which have specific reporter genes downstream of these 5' regions are available.The specific objectives of this proposal are1) to develop short-term screening assays to detect tumor promoters using cell lines stably transfected with specifi constructs containing reporter genes under control of phorbol ester responsive elements,2) to establish the validity of the assay using known tumor promoters and other agents, and3) to test the reporter assay for tumor promoters using test compounds and to determine if positive agents stimulate expression through the protein kinase C pathway.This assay should provide short-term assays which could be automated in the future fo high volume screening. The reporter gene assay for tumor promoters could have significant commercial and scientific value. This assay in combination with short-term assays for detection of mutagens (Ames test) would be of extreme value in assessing the risk of cancer causing agents.National Institute of Environmental Health Sciences (NIEHS)

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----